Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in France / NCT06047600
Recruiting Not applicable

Optimization of the Surgical Care Pathway for Kidney Tumors by Digitizing Perioperative Nursing Coordination (UroCCR 126)

NCT06047600 · tracked via the Priya Life Science France tracker
Sponsor
University Hospital, Bordeaux
Phase
Not applicable
Started
2023-10-23
Last updated
2025-06-19

Condition(s) studied

Digitizing Perioperative Nursing Coordination

Investigational drug(s) / intervention(s)

Uroconnect Follow Up Group

Uroconnect Follow Up Group: Inplementation of UroConnect remote monitoring Medical Device (DM) to optimize patient support and nursing coordination.

Study summary

The project proposes to evaluate the interest of the UroConnect remote monitoring Medical Device (DM) to optimize patient support and nursing coordination

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Planned surgical management by total or partial nephrectomy for kidney tumor, * Affiliation or beneficiary of the French social security * Expressed consent for integration of the UroCCR cohort, * Expressed consent to participate in the DiPRU study. Exclusion Criteria: * Difficulties understanding and expressing oneself in French * Participant under guardianship or curatorship * Pregnancy at the time of surgery * No internet access

Primary outcome measure(s)

  • Number of unscheduled and uncoordinated care utilizations — 30 post-operative days
    In the 30 post-operative days, number of unscheduled and uncoordinated care utilizations (emergency visits, re-hospitalizations in urology, general medicine or urology consultations) corresponding to the difference between the use of care identified in the National health data system (SNDS) and scheduled and coordinated care, identified in the patient file of the initial hospitalization for scheduled care and by the coordinating nurse for coordinated care.

Trial sites (11)

FacilityCityRegionStatus
CHU d'Angers Angers France Recruiting
CHU de Bordeaux Bordeaux France Recruiting
Centre Catalan d'Urologie Cabestany France Recruiting
CHU de Caen Caen France Recruiting
Hôpital Henri Mondor Créteil France Recruiting
APHM Marseille France Recruiting
CH de Mont de Marsan Mont-de-Marsan France Recruiting
CHU de Nantes Nantes France Recruiting
CHU de Nîmes Nîmes France Recruiting
CHU de Strasbourg Strasbourg France Recruiting
CHu de Toulouse Toulouse France Recruiting

More University Hospital, Bordeaux trials in France

Labor Induction in Low-risk Nulliparous Women at 39 Weeks of Gestation to Reduce Cesarean: A Randomized Trial of Induction Versus Expectant Management in France (FRENCH-ARRIVE) Recruiting
SAGE-Heart : Senior Assessment fraGility and Post-opErative QALYs 1 Year After Emergency HEART Surgery for Patients Aged 75 and Older Recruiting
Venetoclax in Association With 3+7 and Midostaurin in FLT3-mutated Acute Myeloid Leukemia Starting soon
Modeling the Early Stages of Autoimmunity Through the Study of Immunological Thrombocytopenic Purpura and Juvenile Lupus Starting soon
Outpatient Holmium LASER Enucleation of the Prostate: Benefit of MOSES(TM) 2.0 Technology Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06047600 on ClinicalTrials.gov ↗ ← All trials in France